Watson’s Bupropion XL Undone By Outlier Patient, Bankrupt CRO

After long delay, FDA quietly reveals second Wellbutrin generic deemed not therapeutically equivalent; ex-Office of Generic Drugs official predicts FDA will tighten criteria for extrapolating data to higher generic strengths.